MGO One Seven’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,123
Closed -$949 773
2022
Q3
$949 Sell
14,123
-181
-1% -$13.3K 0.04% 254
2022
Q2
$1.1M Buy
+14,304
New +$1.12M 0.15% 160

Other funds holding PPH

MGO One Seven's PPH Position: Q4 2022 in Review

MGO One Seven sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2022, closing a stake of 14,123 shares — an estimated $949 sold.

MGO One Seven first reported a position in PPH in Q2 2022 and held it in 2 quarters. The position peaked at $1.1M in Q2 2022. 114 funds tracked by Wall St. Rank hold PPH as of Q4 2022.

  • MGO One Seven reported no remaining VanEck Pharmaceutical ETF position as of Q4 2022 after selling out during the quarter.
  • MGO One Seven sold 14,123 VanEck Pharmaceutical ETF shares in Q4 2022, an estimated $949.
  • MGO One Seven first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 2 quarters.
  • MGO One Seven's VanEck Pharmaceutical ETF position peaked at $1.1M in Q2 2022.
  • 114 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2022.

Based on MGO One Seven's 13F filing for Q4 2022, filed 25 Jan 2023.